Jufrizal Syahri

Dr. Jufrizal Syahri

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Verified
Journal Article
Open access
EYEmmy Yuanita
Emmy Yuanita
SUSudirman
Sudirman
NDNi Komang Tri Dharmayani
Ni Komang Tri Dharmayani
MUMaria Ulfa
Maria Ulfa
JSJufrizal Syahri
Jufrizal Syahri
Quantitative structure–activity relationship (QSAR) and molecular docking approach were carried out to design novel anti-tuberculosis agents based on xanthone derivatives. QSAR designed new compounds were calculated by Austin Model 1 (AM1) methods and analysis of multi-linear regression (MLR). The result showed that the best model as follows: Log IC50 = 3.113 + 11.627 qC1 + 15.955 qC4 + 11.702 qC9, this result has appropriate some statistical parameters (PRESS = 2.11, r2 = 0.730, SEE = 0. 3545, R = 0.6827, FCal/FTab = 4.68), and being used to design a potential anti-tuberculosis drugs with substituted amide, sulfoxide, and carboxylate group xanthone scaffold by a number of their inhibitory concentration (IC50). The mechanism action of sulfonamide substituted on the xanthone scaffold as anti-tuberculosis was carried out using molecular docking. Docking inhibition studies were carried out on MTB C171Q receptor (4C6X.pdb) as KasA inhibitors using by the discovery studio. Based on the binding interaction showed, the sulfonamide substituted xanthone has potential being the anti-tuberculosis drugs by KasA inhibitor for target drug activity.

8 December 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
JSJufrizal Syahri
Jufrizal Syahri
RHRahmiwati Hilma
Rahmiwati Hilma
AAAmatul Hamizah Ali
Amatul Hamizah Ali
NINorzila Ismail
Norzila Ismail
NLNg Yee Ling
Ng Yee Ling
JLJalifah Latip
Jalifah Latip
Research on the antimalarial effect of aminoalkyl chalcone derivatives against Plasmodium falciparum and Plasmodium knowlesi has bolstered efforts in drug discovery to combat cases of drug resistance.

5 June 2020 in Journal of Applied Pharmaceutical Science
Verified
Journal Article
Open access
JSJufrizal Syahri
Jufrizal Syahri
HNHasmalina Nasution
Hasmalina Nasution
BNBeta Achromi Nurohmah
Beta Achromi Nurohmah
BPBambang Purwono
Bambang Purwono
EYEmmy Yuanita
Emmy Yuanita
Three chalcone derivatives with amine groups (4a–c) were synthesized and evaluated for their antimalarial activity. Three aminoalkylated chalcone derivatives (4a–c) have been prepared through Claisen–Schmidt condensation reaction from vanillin and chloroacetophenone, followed by the Mannich reaction to add amine group. The structure of the compounds was confirmed by the spectrophotometric analysis using mass spectrometers (MS) and proton and carbon nuclear magnetic resonance (1H- and 13C-NMR) spectroscopy. Antimalarial activity of 4a–c was evaluated against Plasmodium falciparum (3D7) strain, and the molecular docking of 4b was performed to understand the interaction against Pf DHFR-TS protein (1J3I.pdb). The prepared aminoalkylated chalcone (4a–c) was obtained in a yield of 80%, 75%, and 70%. The addition of morpholine (4a), piperidine (4b), and diethylamine (4c) as amine groups significantly could improve the antimalarial activity with IC50 of 0.62, 0.54, and 1.12 μM, respectively (strong activity), compared with the chalcone without amine group (3) with IC50 of 25.84 μM (moderate activity). The molecular docking of compound 4b exhibited strong hydrogen bond interaction with ILE112, ILE64, SER111, SER108, ASP54, TYR170, and PRO113 residues with CDOCKER interaction energy of −48.84 kcal/mol. Thus, aminoalkylated chalcone could be proposed for further studies and developed into antimalarial drug candidates.

1 May 2019 in Chemistry Journal of Moldova
Verified
Journal Article
Open access
EYEmmy Yuanita
Emmy Yuanita
HPHarno Dwi Pranowo
Harno Dwi Pranowo
MMMustofa Mustofa
Mustofa Mustofa
RSRespati Tri Swasono
Respati Tri Swasono
JSJufrizal Syahri
Jufrizal Syahri
JJJumina Jumina
Jumina Jumina

17 November 2021 in Indonesian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
ISIka Septiana
Ika Septiana
BPBambang Purwono
Bambang Purwono
CAChairil Anwar
Chairil Anwar
BNBeta Achromi Nurohmah
Beta Achromi Nurohmah
JSJufrizal Syahri
Jufrizal Syahri
Series of 2-aryl-4,5-diphenyl-1H-imidazole derivatives of 2-(4-hydroxy-3-methoxyphenyl)-4,5-diphenyl-1H-imidazole (1), 2-(4,5-dimethoxyphenyl)-4,5-diphenyl-1H-imidazole (2) and 2-(4-methoxyphenyl)-4,5-diphenyl-1H-imidazole (3) were produced and evaluated for their in vitro antimalarial activities against the chloroquine-sensitive Plasmodium falciparum 3D7 strain. A molecular docking study was also carried out against the crystal protein of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase (PfDHFR-TS) (PDB ID: 1J3I.pdb) to predict the interaction between the compounds and protein. The physicochemical and pharmacokinetic parameters were computationally performed to predict the parameters of the absorption, distribution, metabolism, excretion, and toxicity (ADMET). Imidazoles were synthesized from aryl aldehyde derivatives with benzyl and ammonium acetate in glacial acetic acid using microwave-assisted-organic synthesis. Compounds 1, 2, and 3 were produced in 64.33, 50.56, and 70.55% yields, respectively. The IC50 of compounds 1, 2, and 3 against chloroquine-sensitive Plasmodium falciparum 3D7 strain was found to be 1.14, 5.28, and 2.42 µM, respectively. The molecular docking study agreed with the in vitro data by showing the lowest CDOCKER energy for compound 1 (-47.48 kcal/mol), followed by 3 (-43.79 kcal/mol) and 2 (-41.47 kcal/mol). The physicochemical and pharmacokinetic parameters showed that imidazoles 1, 2, and 3 obeyed Lipinski rules of five to propose as lead compounds for the antimalarial agents.

4 June 2020 in AIP Conference Proceedings
Verified
Conference Paper
Closed access
PDF file
EYE. Yuanita
E. Yuanita
ISI. M. Sudarma
I. M. Sudarma
NSN. M. Sudewiningsih
N. M. Sudewiningsih
JSJufrizal Syahri
Jufrizal Syahri
NDN. K. T. Dharmayani
N. K. T. Dharmayani
ISI. Sumarlan
I. Sumarlan
Antibacterial assay of series hydroxyxanthone that was a synthesis via cyclization of phenol derivatives and acid derivatives with Eaton Reagent has been investigated through Escherichia coli, Bacillus cereus, Staphylococcus aureus and Salmonella typhimurium by diffusion well method. The possess antibacterial activity against Methicillin-resistant Staphylococcus aureus (MRSA) has been reported by molecular docking. The result reveals that the 1,3,6-tryhydroxyxanthone were effective in inhibiting the growth of Escherichia coli, Bacillus cereus, Staphylococcus aureus and Salmonella typhimurium in the inhibition zone of 30, 30, 35, than 34 mm respectively with MIC at 10%. There was a binding interaction between 1,3,6-tryhydroxyxanthone and the amino acid residues such as His38, His35, Val177, Lys150 and Met41 into methicillin-resistant Staphylococcus aureus (MRSA) (2x3f.pdb).